228 related articles for article (PubMed ID: 38476515)
1. Association of Squamous Cell Carcinoma and Hyaluronan: A Scope of the Literature.
Al Ghanim K; Jaszkul KM; Simpson A; Turley EA
Eplasty; 2024; 24():e11. PubMed ID: 38476515
[TBL] [Abstract][Full Text] [Related]
2. Sun protection for preventing basal cell and squamous cell skin cancers.
Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163
[TBL] [Abstract][Full Text] [Related]
3. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
[TBL] [Abstract][Full Text] [Related]
4. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma.
Piipponen M; Riihilä P; Nissinen L; Kähäri VM
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572732
[TBL] [Abstract][Full Text] [Related]
5. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
[TBL] [Abstract][Full Text] [Related]
6. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
7. CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.
Quadri M; Tiso N; Musmeci F; Morasso MI; Brooks SR; Bonetti LR; Panini R; Lotti R; Marconi A; Pincelli C; Palazzo E
J Exp Clin Cancer Res; 2023 Jul; 42(1):167. PubMed ID: 37443031
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma of the skin: Emerging need for novel biomarkers.
Kivisaari A; Kähäri VM
World J Clin Oncol; 2013 Nov; 4(4):85-90. PubMed ID: 24926428
[TBL] [Abstract][Full Text] [Related]
9. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
10. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat.
Tian X; Azpurua J; Hine C; Vaidya A; Myakishev-Rempel M; Ablaeva J; Mao Z; Nevo E; Gorbunova V; Seluanov A
Nature; 2013 Jul; 499(7458):346-9. PubMed ID: 23783513
[TBL] [Abstract][Full Text] [Related]
11. The Role of Radiation Therapy in the Treatment of Non-Melanoma Skin Cancer.
Yosefof E; Kurman N; Yaniv D
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173875
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
13. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
14. Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma.
Gopinatha Pillai MS; Aiswarya SU; Keerthana CK; Rayginia TP; Anto RJ
iScience; 2023 Jun; 26(6):106816. PubMed ID: 37235052
[TBL] [Abstract][Full Text] [Related]
15. [The anti-tumor mechanisms in long-lived rodents].
Dong YJ; Pang Y; Li QW
Yi Chuan; 2016 May; 38(5):411-7. PubMed ID: 27232489
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.
Fania L; Didona D; Di Pietro FR; Verkhovskaia S; Morese R; Paolino G; Donati M; Ricci F; Coco V; Ricci F; Candi E; Abeni D; Dellambra E
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33572373
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
19. Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway.
Patil K; Khan AQ; Ahmad F; Kuttikrishnan S; Anver R; Mateo JM; Ahmad A; Bhat AA; Buddenkotte J; Steinhoff M; Uddin S
Front Biosci (Landmark Ed); 2024 Jan; 29(1):40. PubMed ID: 38287817
[TBL] [Abstract][Full Text] [Related]
20. YAP1/Piezo1 involve in the dynamic changes of lymphatic vessels in UVR-induced photoaging progress to squamous cell carcinoma.
Yang YL; Zhou C; Chen Q; Shen SZ; Li JD; Wang XL; Wang PR
J Transl Med; 2023 Nov; 21(1):820. PubMed ID: 37974224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
